Alexis Martin

Part of IFP Intermoney Financial Products SA, IFP Asset Management SA is a Swiss financial company that offers different services, including developing new financial products and services directly or via its established subsidiaries. The company is based in Pully, Switzerland and was founded in 1991 by the actual chairman of the board and partner of the company. The company serves its institutional customers in a dedicated way and is a securities dealer approved by the Swiss authorities since 1993, and a fund distributor since 2003. IFP Asset Management is AML compliant under ARIF number 989. Sylvain Naggar has been the CEO of the company since 2003.

Banque Lombard Odier & Cie SA (Investment Management) (Lombard Odier-IM) is the investment management division of Banque Lombard Odier & Cie, a subsidiary of Compagnie Lombard Odier SCmA in Switzerland. The firm was founded in 2002 when Lombard Odier & Cie and Darier Hentsch & Cie. merged. They are headquartered in Geneva with branches and representative offices throughout Switzerland, Europe, the Americas, Asia Pacific and the Middle East. Lombard Odier-IM provides private banking and asset management services to institutions, family-owned businesses and high-net worth individuals. They also provide a range of support services for independent intermediaries.

Champeil SA is an independent and family-run investment management firm headquartered in Bordeaux, France. The firm was founded by Jean-Louis Champeil and formerly known as Champeil Asset Management SA. Champeil offers a tailor-made approach to financial markets for private, wealthy and/or corporate clients.

Champeil SA (Broker) is the securities brokerage division of Champeil SA, a family-owned and independent financial services provider headquartered in Bordeaux, France. Founded by Jean-Louis Champeil, the firm provides full spectrum of brokerage services to private and institutional clients.

SCOR Investment Partners SE (SCOR IP) is the asset management subsidiary of SCOR SE (EPA: SCR) in France. The firm is headquartered in Paris and was founded in 2008. SCOR IP provides investment advisory services and investment strategies in loans, credit and convertible bonds and insurance-linked securities.

Rothschild & Co. Asset Management SCS (Rothschild & Co. AM) is the asset management subsidiary of Rothschild et CIE Banque SC, ultimately held by Rothschild & Co. SCA (EPA: ROTH) in France. Headquartered in Paris, Rothschild & Co. AM offers a range of asset management services which includes equities, fixed-income, convertible bonds and flexible diversified funds to institutional clients, external distributors and independent financial advisors.

Ostrum Asset Management SA (Ostrum AM) is the asset management subsidiary of Natixis Investment Managers International SA, ultimately held by BPCE SA's Natixis SA (Euronext: KN) in France. Headquartered in Paris, the firm was founded in 1984 and provides a full range of active fixed-income and equity expertise, along with tailored insurance investment management solutions and alternative strategies for institutional clients, individual investors and distributors. Ostrum AM is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UN PRI) which integrates environmental, social, and governance considerations into their investment process.

Advance Partners SA provides brokerage services. The private company is based in Zurich, Switzerland. and has subsidiaries in Cayman Islands. The Swiss company was founded in 2006 by Alexis Dawance.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.